Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes Researchers at the University of ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Stronger muscles might be able to ward off some of the organ damage associated with obesity. People with excess body fat who also had stronger handgrip strength were less likely to develop ...

Incorporating metformin in burn metabolic care may help control hyperglycemia and broader metabolic dysfunction linked to ...

Introduction: Type 2 diabetic kidney disease (T2DKD) is a major cause of end-stage renal disease and exhibits marked sex differences in onset and progression. NO is a key regulator of renal function ...

Vitamin B12 plays a crucial role in maintaining a healthy nervous system; its deficiency can lead to nerve damage, resulting ...

But, should your kidneys fail to work properly, your GP will recommend discontinuing metformin and switching to a different ... its deficiency can lead to nerve damage, resulting in sensations of ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.